找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiac Arrhythmias 2003; Proceedings of the 8 Antonio Raviele Conference proceedings 2004 Springer-Verlag Italia 2004 Cardiac arrhythmias.

[復(fù)制鏈接]
樓主: 導(dǎo)彈
21#
發(fā)表于 2025-3-25 07:09:30 | 只看該作者
What Is the Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy?oped their arrhythmia before the age of 50 years, and these patients were at greater risk of clinical deterioration and HCM-related death than were patients with AF onset later in life [4]. Finally, postoperative AF occurred following surgical septal myectomy in approximately 30% of patients in one series [13].
22#
發(fā)表于 2025-3-25 07:50:45 | 只看該作者
23#
發(fā)表于 2025-3-25 14:51:09 | 只看該作者
Conference proceedings 2004gical advances, to communicate results of relevant and innovative researches, to assess the impact of recently developed diagnostic and therapeutical tools, to discuss controversial aspects, and to reach a consensus on the most appropriate evaluation and management of specific problems. This is the
24#
發(fā)表于 2025-3-25 19:26:12 | 只看該作者
25#
發(fā)表于 2025-3-25 21:47:50 | 只看該作者
26#
發(fā)表于 2025-3-26 01:05:31 | 只看該作者
https://doi.org/10.1007/978-94-015-8763-1ctor of mortality in the general population [5], in elderly subjects [6], and in selected groups of patients with hypertension [7] or myocardial infarction [8]. At present the prognostic value of resting HR in patients with chronic atrial fibrillation (AF) is unknown; however, it should be expected to be the same.
27#
發(fā)表于 2025-3-26 04:43:43 | 只看該作者
https://doi.org/10.1007/978-94-015-8763-1c agents may increase the percentage of patients who maintain sinus rhythm, but the overall efficacy is limited and, except for amiodarone, no more than 50% of the treated patients are free from arrhythmia recurrences after 6–12 months. For amiodarone, efficacy rates of 75%–78.5% at 6 months and of 50%–73% at 12 months have been reported.
28#
發(fā)表于 2025-3-26 11:01:37 | 只看該作者
29#
發(fā)表于 2025-3-26 13:17:09 | 只看該作者
30#
發(fā)表于 2025-3-26 17:00:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 13:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
天水市| 罗源县| 措美县| 徐闻县| 金堂县| 东至县| 樟树市| 宁津县| 肇州县| 阿拉善右旗| 焦作市| 芮城县| 巴马| 嘉兴市| 福海县| 鄢陵县| 亚东县| 徐州市| 岳阳县| 陵川县| 株洲县| 蓝山县| 西乡县| 霸州市| 铜梁县| 子洲县| 南康市| 彝良县| 台东市| 锡林郭勒盟| 喜德县| 大荔县| 精河县| 乌拉特中旗| 宁城县| 龙海市| 洛宁县| 三穗县| 麻栗坡县| 房山区| 六安市|